Hofseth Biocare ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the “Subsequent Offering“).This information is published in accordance with the requirements of the Continuing Obligations.